Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains

We compared the efficacy of telavancin (TLV) and daptomycin (DAP) in an experimental rabbit endocarditis model caused by two clinically derived daptomycin-resistant (DAP(r)) methicillin-resistant Staphylococcus aureus (MRSA) strains. TLV treatment significantly reduced MRSA densities in all target t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Abdelhady, Wessam, Bayer, Arnold S., Gonzales, Rachelle, Li, Liang, Xiong, Yan Q.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2017
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278724/
https://ncbi.nlm.nih.gov/pubmed/27872064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01877-16
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы